1. IMPORTANT: In the next few weeks, we will be upgrading the message board software. We expect minimal downtime during the upgrade, and we will attempt to complete this during low-traffic hours. We will post an exact time several days ahead of the switch.

    In preparation for the upgrade, we will be performing board maintenance, such as moving boards to Lost Civilizations where appropriate. Lost Civilizations is a category for companies that have either been dissolved or acquired. The boards serve as both an archive of the old company posts, as well as a place for former employees to reminisce or reconnect, as they will remain open for posting. We may also remove some board threads that have been inactive for several years.
    Dismiss Notice

Amgen up $38 after hours

Discussion in 'Bristol-Myers Squibb' started by anonymous, May 2, 2024 at 5:29 PM.

Tags: Add Tags
  1. #1 anonymous, May 2, 2024 at 5:29 PM
    anonymous

    anonymous Guest

    Q1 earnings reported and stock pops almost $40 a share after hours. Since we sold off Otezla in 2019, their stock is up 67% while ours is down for a 52%.

    Great trade off guys. Well played.

    Amgen opened this morning at 277 and is now at 314.
     
    Quote

  2. #2 anonymous, May 2, 2024 at 7:19 PM
    anonymous

    anonymous Guest

    Has nothing to do with Otezla. They are entering the obesity drug market, just like all the other successful, non-laying off big pharma companies
     
    Quote
  3. #3 anonymous, May 2, 2024 at 7:29 PM
    anonymous

    anonymous Guest

    and we are entering the one market where patients who need the drug will not take it....
     
    Quote
  4. #4 anonymous, May 2, 2024 at 7:34 PM
    anonymous

    anonymous Guest

    That after hours increase was certainly not driven by Otezla. However, in the news for other things that have no impact on your performance https://weartv.com/news/local/warm-may-in-the-forecast-for-northwest-florida#
     
    Quote
  5. #5 anonymous, May 3, 2024 at 7:40 AM
    anonymous

    anonymous Guest

    do we have a 40% share yet? Like we reported in June of 2023?
     
    Quote
  6. #6 anonymous, May 3, 2024 at 8:13 AM
    anonymous

    anonymous Guest

    No company is perfect but Amgen appears to be led by business and medical professionals and a well rounded Board. Amgen puts science before the product. BMS appears to put product before science. Performance over the last 15 years is self evident.
     
    Quote
Reply to Thread